Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
The Delhi High Court refused Novo Nordisk’s plea for an interim injunction against Dr. Reddy’s Laboratories over alleged infringement of Indian Patent No. 262697 related to Semaglutide. The Court found the patent prima facie vulnerable to revocation challenges based on prior claiming and lack of inventive step, allowi…
Share This Article
Ready-to-post copy includes the article link.
Delhi High Court Allows Dr. Reddy’s to Continue Exporting Semaglutide Amid Patent Dispute with Novo Nordisk The Delhi High Court refused Novo Nordisk’s plea for an interim injunction against Dr. Reddy’s Laboratories over alleged infringement of Indian Patent No. 262697 related to Semaglutide. The Court found the patent prima... Read the full IIPLA article: https://iipla.org/news/delhi-high-court-allows-dr-reddy-s-to-continue-exporting-semaglutide-amid-patent-dispute-with-novo-nordisk